Lixte Biotechnology Announces the Closing of $4.19 Million Registered Direct Offering

Retrieved on: 2021-03-02 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Lixte Biotechnology Announces the Closing of $4.19 Million Registered Direct Offering. View article details on hiswai:

Excerpt

East Setauket, March 02, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company ...

Article found on: www.biospace.com